Koyfin Home > Directory > Health Care > Horizon Therapeutics > Total Equity

Horizon Therapeutics Total Equity Chart (HZNP)

Horizon Therapeutics annual/quarterly Total Equity from 2010 to 2020.
  • Horizon Therapeutics Total Equity for the quarter ending September 09, 2020 was $3,797m a 42.44% increase of 1,611m year over year
  • Horizon Therapeutics Total Equity for the last 12 months ending September 09, 2020 was $3,797m a 42.44% increase of 1,611m year over year
  • Horizon Therapeutics Annual Total Equity for 2019 was $2,185m a 45.54% increase of 995m from 2018
  • Horizon Therapeutics Annual Total Equity for 2018 was $1,190m a 15.86% increase of 189m from 2017
  • Horizon Therapeutics Annual Total Equity for 2017 was $1,001m a -26.21% decrease of -262m from 2016
Other Balance Sheet Metrics:
  • Horizon Therapeutics Total Assets for the quarter ending December 12, 2018 was $4,146m a 3.46% increase of 144m year over year
  • Horizon Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $434m a -18.99% decrease of -82m year over year
View Chart On Koyfin

Quarterly HZNP Total Equity Data

09/2020$3,797m
06/2020$2,362m
03/2020$2,188m
12/2019$2,185m
09/2019$1,556m
06/2019$1,521m
03/2019$1,504m
12/2018$1,190m
09/2018$917m
06/2018$860m

Annual HZNP Total Equity Data

2019$2,185m
2018$1,190m
2017$1,001m
2016$1,264m
2015$1,313m
2014$540m
2013$-49m
2012$106m
2011$46m
2010$97m